We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$233M
AUM Growth
+$20M
Cap. Flow
+$21.4M
Cap. Flow %
9.22%
Top 10 Hldgs %
39.53%
Holding
45
New
6
Increased
12
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.1M
2
ABBV icon
AbbVie
ABBV
+$6.12M
3
MDT icon
Medtronic
MDT
+$5.5M
4
HUM icon
Humana
HUM
+$4.7M
5
UNH icon
UnitedHealth
UNH
+$4.58M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$2.8M
2
GMED icon
Globus Medical
GMED
+$2.8M
3
SYK icon
Stryker
SYK
+$2.65M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.65M
5
MRNA icon
Moderna
MRNA
+$2.33M

Sector Composition

Rank Sector Weight
1 Healthcare 93.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$15.2M 6.55%
200,000
+25,000
+14% +$2.07M
HUM icon
2
Humana
HUM
$46.2B
$10.9M 4.7%
22,500
+9,500
+73% +$4.7M
NVO
3
Novo Nordisk
NVO
$209B
$9.55M 4.1%
120,000
+20,000
+20% +$1.42M
THC icon
4
Tenet Healthcare
THC
$21.1B
$8.91M 3.83%
150,000
-15,000
-9% -$834K
UNH icon
5
UnitedHealth
UNH
$370B
$8.27M 3.56%
17,500
+9,500
+119% +$4.58M
MRK icon
6
Merck
MRK
$318B
$7.98M 3.43%
+75,000
New +$8.1M
HCA icon
7
HCA Healthcare
HCA
$89.5B
$7.91M 3.4%
30,000
-5,000
-14% -$1.27M
BSX icon
8
Boston Scientific
BSX
$71.5B
$7.75M 3.33%
155,000
-30,000
-16% -$1.41M
ZBH icon
9
Zimmer Biomet
ZBH
$18.4B
$7.75M 3.33%
60,000
– –
ISRG icon
10
Intuitive Surgical
ISRG
$134B
$7.66M 3.29%
30,000
– –
SYK icon
11
Stryker
SYK
$130B
$7.14M 3.07%
25,000
-10,000
-29% -$2.65M
UHS icon
12
Universal Health Services
UHS
$10.5B
$6.99M 3%
54,990
-10
-0% -$1.38K
LLY icon
13
Eli Lilly
LLY
$1.06T
$6.87M 2.95%
20,000
+2,500
+14% +$843K
COR icon
14
Cencora
COR
$61.2B
$6.4M 2.75%
40,000
+10,000
+33% +$1.59M
ABBV icon
15
AbbVie
ABBV
$435B
$6.38M 2.74%
+40,000
New +$6.12M
TMO icon
16
Thermo Fisher Scientific
TMO
$220B
$6.34M 2.73%
11,000
– –
BAX icon
17
Baxter International
BAX
$14.2B
$6.08M 2.62%
150,000
– –
CAH icon
18
Cardinal Health
CAH
$55.4B
$6.04M 2.6%
80,000
+10,000
+14% +$754K
SGRY icon
19
Surgery Partners
SGRY
$2.03B
$6.03M 2.59%
175,000
+10,000
+6% +$325K
A icon
20
Agilent Technologies
A
$41.2B
$5.53M 2.38%
40,000
– –
MDT icon
21
Medtronic
MDT
$112B
$5.44M 2.34%
+67,500
New +$5.5M
MCK icon
22
McKesson
MCK
$101B
$5.34M 2.3%
15,000
– –
ACHC icon
23
Acadia Healthcare
ACHC
$2.94B
$5.06M 2.17%
70,000
– –
DHR icon
24
Danaher
DHR
$144B
$5.04M 2.17%
22,560
– –
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12.4B
$4.86M 2.09%
50,000
-10,000
-17% -$1.04M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2023 Portfolio in Review

As of Q1 2023, Sivik Global Healthcare held 45 positions worth $233M, up 9.4% from $213M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sivik Global Healthcare deployed $21.4M of net new capital in Q1 2023, opening 6 new positions and adding to 12 existing holdings. Its largest new stake was Merck: 75,000 shares worth $7.98M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 93% a quarter earlier.

On the sell side, the largest reduction was Stryker, an estimated $2.65M trimmed.

  • Sivik Global Healthcare's largest Q1 2023 buy was Merck: 75,000 shares worth $7.98M.
  • Sivik Global Healthcare added most to Humana in Q1 2023, an estimated $4.7M increase.
  • Sivik Global Healthcare's biggest Q1 2023 reduction was Stryker, cutting an estimated $2.65M.
  • Sivik Global Healthcare fully exited Revvity in Q1 2023, selling an estimated $2.8M.
  • Sivik Global Healthcare's ten largest holdings make up 40% of its $233M portfolio in Q1 2023.
  • Sivik Global Healthcare opened 6 new positions and closed 5 in Q1 2023.
  • Sivik Global Healthcare's portfolio value rose 9.4% quarter-over-quarter to $233M.

Based on Sivik Global Healthcare's 13F filing for Q1 2023, filed 8 May 2023.